Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Upgrades Ambev to Overweight

JP Morgan Upgrades Ambev to Overweight

JP Morgan analyst Lucas Ferreira upgrades Ambev (NYSE:ABEV) from Neutral to Overweight.

byBenzinga Newsdesk

July 13, 2022

1 minute read

JP Morgan analyst Lucas Ferreira upgrades Ambev (NYSE:ABEV) from Neutral to Overweight.

Deutsche Bank Maintains Buy on Penumbra, Raises Price Target to $297

By Benzinga Newsdesk

February 7, 10:50 AM

Deutsche Bank analyst Pito Chickering maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $250 to $297.

PEN

Rising Brent Crude Prices Could Tighten US Interest Rates, Warn Economists

By Piero Cingari

September 6, 10:27 AM

Once again in the spotlight, Brent crude oil prices, are at their highest levels this year. This is…

QQQ

Clover Health Investments Q4 Sales $898.79M Beat $785.38M Estimate

By Bill Haddad

February 28, 7:41 AM

Clover Health Investments (NASDAQ:CLOV) reported quarterly sales of $898.79 million which beat the analyst consensus estimate of $785.38 million by 14.44 percent. This is a 108.04 percent increase over sales of $432.04

CLOV

Analyst Ratings

What 11 Analyst Ratings Have To Say About Union Pacific

By Benzinga Insights

April 4, 9:00 AM

Analysts have provided the following ratings for Union Pacific (NYSE:UNP) within the last quarter: Bullish Somewhat Bullish Indifferent…

UNP

JP Morgan Upgrades Ambev to Overweight

Related Posts

Deutsche Bank Maintains Buy on Penumbra, Raises Price Target to $297

Rising Brent Crude Prices Could Tighten US Interest Rates, Warn Economists

Clover Health Investments Q4 Sales $898.79M Beat $785.38M Estimate

What 11 Analyst Ratings Have To Say About Union Pacific